Advanced BRAF Mutant Cancers Completed Phase 1 / 2 Trials for Binimetinib (DB11967)

Also known as: Advanced BRAF-mutant Cancers

IndicationStatusPhase
DBCOND0117671 (Advanced BRAF Mutant Cancers)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03843775A Study of Binimetinib and Encorafenib in Advanced BRAF Mutant CancersTreatment